Nicholas Investment Partners, LP Personalis, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$8.73 - $12.95 $2.85 Million - $4.23 Million
-326,269 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$14.16 - $25.34 $900,760 - $1.61 Million
63,613 Added 24.22%
326,269 $4.79 Million
Q2 2019

Aug 09, 2019
BUY
$27.0 - $30.25 $7.09 Million - $7.95 Million
262,656 New
262,656 $7.13 Million

Others Institutions Holding PSNL

# of Institutions
91
Shares Held
30.1M
Call Options Held
27.5K
Put Options Held
85.4K
View Full List

About Personalis, Inc.

PSNL Quotes by TradingView
  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email